Please join us in welcoming the following new corporate partners contributing their support to the HBA mission.
CEO: Justin Gover
GW Pharmaceuticals (GW), along with its U.S. subsidiary Greenwich Biosciences, is a pioneering global biopharmaceutical company that has established a world-leading position in cannabinoid science and medicines over the last 20 years. GW’s mission is to transform the lives of seriously ill patients through developing and delivering rigorously tested cannabis-derived pharmaceutical medicines with documented safety and efficacy profiles, approved by regulators and manufactured to the highest standards.
GW’s research efforts initially focused on the unmet needs of patients with Multiple Sclerosis (MS), while in recent years the company has focused on helping children and adults with severe, life-threatening forms of epilepsy. Looking to the future, GW’s deep scientific knowledge and extensive body of research is enabling the Company to explore new therapeutic areas including neurology, oncology, psychiatry and autism spectrum disorders.
More than 6,000 patients globally have been involved in GW’s clinical trials, and the Company has collected more than 80,000 years of human safety data, been featured in 80 peer-reviewed publications, and generated high-quality evidence which has appeared in the New England Journal of Medicine and The Lancet. In October 2018, TIME magazine named GW one of the 'Top 50 Genius Companies of 2018 That Are Inventing the Future' in recognition of this work.
CEO: Robert Azelby
Alder BioPharmaceuticals is a biopharmaceutical company focused on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies.
CEO: Jeff Boutelle
Pharmavite is a leader in the health and wellness industry, earning the trust of healthcare professionals, consumers, and retailers by manufacturing high-quality nutrition products and solutions under its Nature Made®, EQUELLE, MegaFood, and Innate Response brands. Pharmavite is dedicated to helping people live healthier, more vital lives by producing the highest quality products and providing trust and transparency. Based in California, Pharmavite LLC is a subsidiary of Otsuka Pharmaceutical Co., Ltd.
CEO: Peter Hecht, PhD
Creating breakthrough treatments for patients with serious and orphan diseases by harnessing the power of soluble guanylate cyclase (sGC), a key element of a powerful and clinically precedented biological pathway, through the development of targeted sGC stimulators.